Dynamic changes of early-stage aortic lipid deposition in chronic renal failure rats and effects of decorin gene therapy

Ma,Hong‑Bo; Wang,Rong; Yu,Ke‑Zhou; Yu,Che

doi:10.3892/etm.2014.2106

Dynamic changes of early-stage aortic lipid deposition in chronic renal failure rats and effects of decorin gene therapy

Authors:
- Hong‑Bo Ma
- Rong Wang
- Ke‑Zhou Yu
- Che Yu
View Affiliations

Affiliations: Department of Nephrology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China
Published online on: December 4, 2014 https://doi.org/10.3892/etm.2014.2106
Pages: 591-597

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to clarify the association between lipid metabolism and the atherosclerosis in early‑stage chronic renal failure at the molecular level and to explore the efficacy of decorin on chronic renal failure. Sprague Dawley rats receiving 5/6 nephrectomy and Sham surgery were divided into control and experimental groups. Sprague Dawley rats receiving 5/6 nephrectomy were divided into control and experimental groups, and the experimental group was further subdivided into rats receiving treatment with fibroblasts (FBs) transfected either with empty vector and with a decorin (DCN) gene. The dynamic levels of triglyceride (TG), total cholesterol (T‑Ch) and total phospholipid (T‑PL) were detected on the 10th, 30th and 60th days. The body weight, blood lipid levels, renal function and renal tissue were observed after four weeks, and transforming growth factor‑βl and protein expression was detected by immunohistochemistry. In total, 4 weeks after treatment, the DCN expression in the renal tissue of rats treated with DCN-transfected FBs was significantly increased compared to that in the control rats. The results showed that the levels of the three lipids in the aortic arches were slightly elevated on the 10th day compared with those in the control group, and the TG level was significantly increased on the 30th day. The levels of T‑Ch, TG and T‑PL in the aortic arches were significantly elevated on the 60th day. The TG and T‑Ch levels in the plasma and aortic tissues of Sprague Dawley rats receiving 5/6 nephrectomy without any treatment and after receiving treatment with FBs transfected with empty vector were significantly increased compared with those in the control group. The increased T‑Ch and decreased T‑PL levels in the erythrocyte membrane increased the rigidity of the erythrocyte and decreased erythrocyte deformability. In conclusion, highly expressed DCN mitigated renal fibrosis and thus delayed renal failure as well as mitigating the abnormal lipid metabolism of the chronic renal failure.

View Figures

View References

1	Wang L, Wang J, Wang Y, Fu Q, Lei YH, Nie ZY, Qiu J and Bao TY: Protective effect of exogenous matrix metalloproteinase-9 on chronic renal failure. Exp Ther Med. 7:329–334. 2014.PubMed/NCBI
2	Bhagwat R, Joshi SP, Salgia P and Sepaha A: Lipid abnormalities in chronic renal failure. Indian J Clin Biochem. 12:81–85. 1997. View Article : Google Scholar : PubMed/NCBI
3	Kim HJ, Moradi H, Yuan J, Norris K and Vaziri ND: Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney. Am J Physiol Renal Physiol. 296:F1297–1306. 2009. View Article : Google Scholar : PubMed/NCBI
4	Muntener P, Coresh J, Smith JC, Eckfeldt J and Klag MJ: Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int. 58:293–301. 2000. View Article : Google Scholar
5	Caimi G, Carollo C, Montana M, Vaccaro F and Lo Presti R: Elastase, myeloperoxidase, nitric oxide metabolites and oxidative status in subjects with clinical stable chronic renal failure on conservative treatment. Clin Hemorheol Microcirc. 43:253–258. 2009.PubMed/NCBI
6	Liu N, Tolbere E, Pang M, Ponnusamy M, Yan H and Zhuang S: Suramin inhibits renal fibrosis in chronic kidney disease. J Am Soc Nephrol. 22:1064–1075. 2011. View Article : Google Scholar : PubMed/NCBI
7	Han JY, Kim YJ, Kim L, Choi SJ, Park IS, Kim JM, Chu YC and Cha DR: PPARgamma agonist and angiotensin II receptor antagonist ameliorate renal tubulointerstitial fibrosis. J Korean Med Sci. 25:35–41. 2010. View Article : Google Scholar : PubMed/NCBI
8	Suzuki S, Ohashi N and Kitagawa M: Roles of the Skp2/p27 axis in the progression of chronic nephropathy. Cell Mol Life Sci. 70:3277–3287. 2013. View Article : Google Scholar :
9	Chen G, Chen H, Wang C, Peng Y, Sun L, Liu H and Liu F: Rapamycin ameliorates kidney fibrosis by inhibiting the activation of mTOR signaling in interstitial macrophages and myofibroblasts. PLoS One. 7:March 28–2012.(Epub ahed of print). View Article : Google Scholar
10	Pedersen EB, Ardal B, Bech JN, Lauridsen TG, Larsen NA, Mikkelsen L, Sangill M and Thomsen IM: The effect of glucose added to the dialysis fluid on blood pressure, vasoactive hormones and energy transfer during hemodialysis in chronic renal failure. Open J Neph. 1:5–14. 2011. View Article : Google Scholar
11	Pohjolainen V, Rysä J, Näpänkangas J, Kööbi P, Eräranta A, Ilves M, Serpi R, Pörsti I and Ruskoaho H: Left ventricular periostin gene expression is associated with fibrogenesis in experimental renal insufficiency. Nephrol Dial Transplant. 27:115–122. 2012. View Article : Google Scholar
12	Mu J, Li YK and Fu SG: Influence of Shenqi Recipe on mesangial cells and interstitial fibroblasts of chronic renal failure rats. Zhong Xi Yi Jie He Xue Bao. 1:122–124. 2003.(In Chinese). View Article : Google Scholar
13	Korish AA and Arafah MM: Catechin combined with vitamins C and E ameliorates insulin resistance (IR) and atherosclerotic changes in aged rats with chronic renal failure (CRF). Arch Gerontol Geriatr. 46:25–39. 2008. View Article : Google Scholar
14	Görs S, Kucia M, Langhammer M, Junghans P and Metges CC: Technical note: Milk composition in mice - methodological aspects and effects of mouse strain and lactation day. J Dairy Sci. 92:632–637. 2009. View Article : Google Scholar
15	Kang NH, Lee WK, Yi BR, Park MA, Lee HR, Park SK, Hwang KA, Park HK and Choi KC: Modulation of lipid metabolism by mixtures of protamine and chitooligosaccharide through pancreatic lipase inhibitory activity in a rat model. Lab Anim Res. 28:31–38. 2012. View Article : Google Scholar : PubMed/NCBI
16	Wasserman DH, Lacy DB, Goldstein RE, Williams PE and Cherrington AD: Exercise-induced fall in insulin and increase in fat metabolism during prolonged muscular work. Diabetes. 38:484–490. 1989. View Article : Google Scholar : PubMed/NCBI
17	Stoof J, Kuipers EJ and van Vliet AH: Characterization of NikR-responsive promoters of urease and metal transport genes of Helicobacter mustelae. Biometals. 23:145–159. 2010. View Article : Google Scholar
18	Lönn J, Shahzad F, Uhlin F, Bengtsson T, Almroth G and Nayeri F: High concentration but low biological activity of hepatocyte growth factor in patients with chronic renal failure. Adv Biosci Biotechnol. 3:516–523. 2012. View Article : Google Scholar
19	Hirako M, Kamiya T, Misu N, Kobayashi Y, Adachi H, Shikano M, Matsuhisa E and Kimura G: Impaired gastric motility and its relationship to gastrointestinal symptoms in patients with chronic renal failure. J Gastroenterol. 40:1116–1122. 2005. View Article : Google Scholar : PubMed/NCBI
20	Sasikala M, Subramanyam C and Sadasivudu B: Early oxidative change in low density lipoproteins during progressive chronic renal failure. Indian J Clin Biochem. 14:176–183. 1999. View Article : Google Scholar : PubMed/NCBI
21	Inaguma D, Tatematsu M, Shinjo H, Suzuki S, Mishima T, Inaba S and Kurata K: Effect of an educational program on the predialysis period for patients with chronic renal failure. Clin Exp Nephrol. 10:274–278. 2006. View Article : Google Scholar : PubMed/NCBI
22	Kuwahara M, Inoshita S, Nakano Y, Terada Y, Takano Y and Sasaki S: Expression of bone type 1 PTH receptor in rats with chronic renal failure. Clin Exp Nephrol. 11:34–40. 2007. View Article : Google Scholar : PubMed/NCBI
23	Sadykov AS, Salikhov ShI, et al: Investigation of membrane-active components from blood serum of patients with chronic renal failure. Bull Exp Biol Med. 94:1408–1410. 1982. View Article : Google Scholar
24	Markou N, Kanakaki M, et al: Sleep-disordered breathing in nondialyzed patients with chronic renal failure. Lung. 184:43–49. 2006. View Article : Google Scholar : PubMed/NCBI
25	Gavrisheva NA, Malinin VV, Ses TP, Kozlov KL, Panchenko AV and Titkov AY: Effect of peptide Vilon on the content of transforming growth factor-beta and permeability of microvessels during experimental chronic renal failure. Bull Exp Biol Med. 139:24–26. 2005. View Article : Google Scholar : PubMed/NCBI
26	Li P, Ma LL, Xie RJ, et al: Treatment of 5/6 nephrectomy rats with sulodexide: a novel therapy for chronic renal failure. Acta Pharmacol Sin. 33:644–651. 2012. View Article : Google Scholar : PubMed/NCBI
27	Pusoonthornthum R, Pusoonthornthum P and Krishnamra N: Calcium-phosphorus homeostasis and changes in parathyroid hormone secretion in cats with various stages of spontaneous chronic renal failure. Comp Clin Pathol. 19:287–293. 2010. View Article : Google Scholar
28	Kihara Y, Matsuno N, Mijiti A, Nagao T, Takeuchi H, Unezaki S and Hirano T: Comparative study of the cellular pharmacodynamics of calcineurin inhibitors between patients with chronic renal failure awaiting renal transplantation and cirrhosis patients awaiting liver transplantation. Cell Transplant. 18:639–646. 2009.PubMed/NCBI
29	Ienaga K, Mikami H and Yokozawa T: First indications demonstrating the preventive effects of NZ-419, a novel intrinsic antioxidant, on the initiation and/or progression of chronic renal failure in rats. Biol Pharm Bull. 32:1204–1208. 2009. View Article : Google Scholar : PubMed/NCBI
30	De Beuf A, D’Haese PC and Verhulst A: Epoetin delta as an antifibrotic agent in the remnant kidney rat: a possible role for transforming growth factor beta and hepatocyte growth factor. Nephron Exp Nephrol. 115:e46–e59. 2010. View Article : Google Scholar : PubMed/NCBI
31	Lin Z, Wang JS, Lin L, et al: Effects of BMP2 and VEGF165 on the osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. Exp Ther Med. 7:625–629. 2014.PubMed/NCBI